Published Date: 26 Apr 2023
In people with allergic asthma, for instance, a vitamin D3 deficiency can cause severe symptoms. Numerous studies have already demonstrated this. But we're still not sure how exactly this vitamin works.
Read Full NewsFindings from a phase 2 trial highlighted lacosamide's effectiveness and safety in treating neonatal seizures, showing significant seizure reduction and tolerability in patients.
Here's some of what is coming soon to NeurologyLive® this week.
Ovid Therapeutics' OV329 shows promise as a safe, effective GABA-AT inhibitor for treating drug-resistant seizures, with strong phase 1 trial results.
FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.
5 Pulmonology Headlines You Missed in November 2025
Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43
Stage 5 CKD May Reverse Female Survival Advantage
1.
Adding cell-based vaccine to liver cancer therapy can slow cancer progression
2.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
3.
Medical Journal March 28, 2023
4.
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer
5.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
1.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
2.
All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment
3.
A Visual Guide to Understanding Breast Cancer Staging
4.
Multiple Myeloma: Understanding the Basics
5.
Genetic Screening: A Game Changer in Cancer Prevention
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
3.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation